Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 751, pseudogene (RN7SL751P)

Target
RN7SL751P
Molecular classification
Other
01

Overview

**RNA, 7SL, cytoplasmic 751, pseudogene (RN7SL751P)** is a member of the large family of 7SL RNA pseudogenes present in the human genome. 7SL RNA is best known as the RNA component of the signal recognition particle (SRP), an essential ribonucleoprotein complex that mediates the targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotes[4][5]. However, *RN7SL751P* is a **pseudogene**, which means it is a nonfunctional, often truncated or mutated, genomic copy of the original 7SL RNA gene and is not transcribed into a functional RNA[5]. The vast majority of 7SL pseudogenes, including RN7SL751P, are derived from the reverse transcription and reintegration of 7SL RNA sequences into the genome, but they **do not encode functional RNA or protein and have no known biological function or disease association**[5]. Therefore, *RN7SL751P is not considered a therapeutic target* of any sort, and there are no known drugs or disease mechanisms linked to its sequence. Key notes: - This "target" is a nonfunctional pseudogene, not a receptor, enzyme, or known functional molecule[5]. - There is no evidence or scientific consensus for any biological function, disease association, or therapeutic potential for RN7SL751P. - The locus is properly referred to as a "7SL RNA pseudogene." It should not be considered an actionable molecular target. - If your interest is in the functional 7SL RNA or the signal recognition particle RNA (SRP RNA), clarify with those canonical names instead[4][5].

Other names
RN7SL751P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 751, pseudogene (RN7SL751P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 751, pseudogene (RN7SL751P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call